Buscar resultados de ensayos clínicos

Patrocinado por

Ichthyosis - 33 Studies Found

Estado Estudiar
Not yet recruiting Nombre del estudio: Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
Condición: Soft Tissue Sarcoma, Adult, Stage II
Fecha: 2017-04-17
Intervenciones: Drug: Apatinib Apatinib 500 mg is administered orally daily, until disease progression or untolerable to
Completed Nombre del estudio: Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Condición: Sarcoma, Soft Tissue
Fecha: 2005-09-13
Intervenciones: Drug: Bendamustin
Active, not recruiting Nombre del estudio: Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)
Condición: Soft Tissue Sarcoma
Fecha: 2015-05-17
Intervenciones:
  • Drug: Anlotinib Anlotinib p.o.
Active, not recruiting Nombre del estudio: Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
Condición: Sarcoma, Soft Tissue
Fecha: 2005-09-13
Intervenciones:
  • Drug: Adriamycin 60 mg/m2, d1,
Completed Nombre del estudio: Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
Condición: Soft Tissue Sarcoma
Fecha: 2011-05-02
Intervenciones:
  • Procedure: External Beam Radiation Therapy (RT)

Not yet recruiting Nombre del estudio: Ph II Nintedanib or Intravenous Ifosfamide Advanced Metastatic STS Failed on Imatinib and Sunitinib
Condición: Sarcoma, Soft Tissue
Fecha: 2016-06-17
Intervenciones:
  • Drug: Nintedanib Pharmaceutica
Completed Nombre del estudio: Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Condición: Sarcoma, Soft Tissue
Fecha: 2005-09-13
Intervenciones:
  • Drug: Adriamycin
  • Drug: Ifosfamide
Completed Nombre del estudio: Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Condición: Soft Tissue Sarcoma
Fecha: 2011-02-10
Completed Nombre del estudio: Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
Condición: Soft Tissue Sarcoma
Fecha: 2009-06-10
Intervenciones: Drug: Vorinostat Daily administration of 400mg vorinostat on 28 days (one therapy cycle). Seven days of
Not yet recruiting Nombre del estudio: Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas
Condición: Soft Tissue Sarcoma
Fecha: 2017-02-01
Intervenciones:
  • Drug: Selinexor Selinexor is a
<<< Previous | Next >>>